Smoking Cessation Intervention for Thoracic Patients

• Status: Completed
• Trial end date: 2012-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary aim of the proposed study is to develop and assess the feasibility of delivering a smoking cessation intervention to patients undergoing lung surgery that begins before surgery and continues up to 3 months post-discharge. The secondary aim is to assess smoking cessation rates 3 months following surgery.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Massachusetts General Hospital
• Collaborator: National Cancer Institute (NCI)
• Treatments: Varenicline

Criteria

Inclusion Criteria:

A patient is eligible if he/she:

1. Is scheduled for a lung resection surgery with either a lung cancer diagnosis or a potential lung cancer diagnosis

2. Smoked a cigarette in the past 2 weeks

3. Is willing to make a pre-surgical quit attempt

Exclusion Criteria:

Patients will be excluded from the intervention group if they are:

1. Non-English speaking

2. Determined medically ineligible by their surgeon

3. Suffering from psychosis or dementia

4. Have been taking Varenicline for longer than three weeks

5. Have been taking Bupropion (for smoking cessation purposes) for more than three weeks

6. Is otherwise unable to participate in the intervention.